Literature DB >> 17333267

Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.

Satomi Kasashima1, Atsuhiro Kawashima, Yoh Zen, Satoru Ozaki, Masako Kobayashi, Akihiko Tsujibata, Hiroshi Minato.   

Abstract

The clinicopathological profiles of histiocytoid carcinoma of the breast have not been well examined because of their rarity and heterogenous groups of ductal and lobular origin. A large foamy or granular cytoplasm of histiocytoid carcinoma was characterized by abundant mucin, but the properties of mucin in histiocytoid carcinoma have also not been well investigated. We selected eight cases of histiocytoid features of invasive lobular carcinoma (HLC) and compared with 14 age- and tumor size-matched cases of classical invasive lobular carcinoma (CLC). Mucin profiles were significantly different between the two groups: a fair number of HLC cases were immunopositive for MUC2 and MUC5AC (75 and 50%, respectively); in contrast, almost all CLC cases showed both as negative. Both groups were immunopositive for MUC1 and negative for MUC4 and MUC6. The prognosis of HLC was significantly worse than CLC; HLC showed shorter disease-free time than CLC (p=0.0262). In particular, HLC with MUC2 and MUC5AC expressions showed significantly shorter disease-free time and survival time than lobular carcinoma without the expressions of MUC2 and MUC5AC (p=0.0055 and p=0.0060, respectively). Therefore, the expression of 'non-mammary mucins', such as MUC2 and MUC5AC in HLC, is characteristic and indicates the more malignant transformation of tumor cells and poorer prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333267     DOI: 10.1007/s00428-007-0381-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Histiocytoid Breast Carcinoma: A Case Report with Immunohistochemical and Ultrastructural Studies.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 2.  Histiocytoid breast carcinoma: a case report of an uncommon histologic variant of lobular carcinoma.

Authors:  I Kostopoulos; S Barbanis; E Mylona; S Papadopoulos; C Papadimitriou
Journal:  Ann Pathol       Date:  2003-06       Impact factor: 0.407

3.  Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues.

Authors:  M B Pereira; A J Dias; C A Reis; F C Schmitt
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

4.  Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Authors:  Emad A Rakha; Richard W G Boyce; Dalia Abd El-Rehim; Thomas Kurien; Andrew R Green; Emma C Paish; John F R Robertson; Ian O Ellis
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

5.  Invasive lobular carcinoma: to grade or not to grade.

Authors:  Anita L Bane; Susanna Tjan; Robert K Parkes; Irene Andrulis; Frances P O'Malley
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

6.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

7.  Pleomorphic variant of invasive lobular carcinoma of the breast.

Authors:  N Weidner; J P Semple
Journal:  Hum Pathol       Date:  1992-10       Impact factor: 3.466

8.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

9.  Breast carcinoma metastatic to eyelids: case report and review of the literature.

Authors:  K Dabski; H Milgrom; H L Stoll
Journal:  J Surg Oncol       Date:  1985-08       Impact factor: 3.454

10.  Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Authors:  R E Hall; J A Clements; S N Birrell; W D Tilley
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more
  6 in total

1.  Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Authors:  Anna Astashchanka; Thomas M Shroka; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2018-10-13       Impact factor: 4.872

Review 2.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

3.  Histiocytoid breast carcinoma: a case report showing immunohistochemical profiles.

Authors:  Peifeng Li; Jinfeng Zheng; Tingguo Zhang; Ruixue Cao; Xin Chen; Ming Geng
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

4.  Histiocytoid variant of invasive lobular breast carcinoma. A case report and literature review.

Authors:  Fozan A Aldulaijan; Abdullah G Alsahwan; Maryam Hussain A Alsulaiman; Miral Mohamed Mashhour; Ahmad Alwabari
Journal:  Ann Med Surg (Lond)       Date:  2021-11-18

5.  High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.

Authors:  Yi-feng He; Mei-ying Zhang; Xin Wu; Xiang-jun Sun; Ting Xu; Qi-zhi He; Wen Di
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

6.  Histiocytoid breast carcinoma, neither lobular nor ductal? A case report and literature review.

Authors:  Xiao-Li Ma; Qian Du; Yang Liu; Rong-Mei Zhao; Shu-Yan Zhang; Huan-Fen Zhao
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.